Developed by former Apple engineers, Clair Labs’s non-contact physiological monitoring device enables clinical-grade biomarker acquisition with consumer ease-of-use. Clair’s technology is designed for long term home monitoring of chronically diseased patients and includes the first clinically proven contactless pulse oximeter in the world.
Adi Berenson | CEO & Co-Founder
Ran Margolin | CTO & Co-Founder
SAN FRANCISCO, Calif., August 25, 2021 — Supermoon Capital (www.supermooncapital.com), formerly SleepScore Ventures, launched today with its first venture fund of $36 million to invest in early-stage startups across all geographies working on science-backed innovations aimed to improve sleep.Read More
Remote patient monitoring company Clair Labs closed on $9 million in seed funding to continue developing its contact-free technology for both hospitals and at-home health care.Read More
Have an idea? Building a company? Seeking to partner with our portfolio companies? Please reach out, we’d love to hear from you.Get In Touch